SMDM 2016 - 38th Annual North American Meeting
THETA Collaborative presents at the Society for Medical Decision Making (SMDM) 2016 - 38th Annual North American Meeting
Place: Vancouver, BC, Canada
Dates: October 23 - October 26, 2016
Theme: From Uncertainty to Action
As Ellen Peters wrote, "uncertainty abounds" in health care decisions. From decision models to decision aids and prediction tools, incorporating and communicating uncertain information is key to transparent, informed decision-making for individuals, clinicians, and policy makers. For over 30 years, SMDM members have sought to improve decision-making while accounting for uncertainty about the magnitude and severity of benefits and risks, the strength of current evidence, and how to weigh risks and benefits from the perspectives of the individual, health system, and society.
THETA's Biostatistician Nicholas Mitsakakis, MSc PhD has been selected to teach a short course at the SMDM 38th Annual North American Meeting. Other staff and THETA students are contributing oral and poster presentations.
Pre-Meeting Short Courses
Issues in the analysis of health care cost data. Nicholas Mitsakakis, MSc PhD, Sunday, Oct 23, 2-5.30pm
Panel: Recommendations of the second panel on cost-effectiveness in health and medicine. Panelists: Anirban Basu, PhD; David Feeny, PhD; Murray Krahn, MD, MSc, FRCPC; Karen M. Kuntz, ScD; David O. Meltzer, MD, PhD; Douglas K. Owens, MD, MS; Lisa A. Prosser, MS, PhD; Joshua A. Salomon, PhD; Thomas Trikalinos, MD, PhD; Chairs: Peter Neumann, ScD; Gillian D. Sanders, PhD
Investigating structural independence in preference-based utility instruments using graphical models. Nicholas Mitsakakis, MSc PhD, Karen E Bremner, BSc and Murray Krahn, MD, MSc, FRCPC
Validating the bladder utility symptom scale (BUSS): a multiattribute health state classification system for all patients with bladder cancer. Kirstin E Boehme, MSc, Nathan Perlis, MD, MSc, Munir Jamal, MD, Karen E Bremner, BSc, Shabbir MH Alibhai, MD, MSc, Antonio Finelli, MD, MSc, Paul Ritvo, PhD, Murray D. Krahn, MD, MSc and Girish Kulkarni, MD, PhD
Exploring the use of decision thresholds for ranking treatments in network meta-analysis. Romina Brignardello, PhD, Alejandro Jadad, MD, DPhil, Bradley Johnston, PhD, George Tomlinson, PhD, Nicholas Mitsakakis, MSc PhD
Cost-effectiveness analysis of drugs for chronic Hepatitis C infection: informing on listing decisions of interferon-free direct-acting antiviral regimens in Canada. William W. L. Wong, PhD, Karen M. Lee, MA, Sumeet Singh, BScPhm, MSc, Murray Krahn, MD, MSc, FRCPC
Weighting of AHI scores and symptoms in the diagnosis of sleep apnea by sleep specialists. Nicholas Mitsakakis, MSc PhD, Lusine Abrahamyan, MD, MPH, PhD, Valeria E. Rac, MD, PhD, Suzanne Chung, BEd, CCRP, Michael Fitzpatrick, MB, BCh, DCH, FRCPI, MD, FRCPC, FAASM and Murray Krahn, MD, MSc, FRCPC
A systematic review and meta-analysis of health utilities in chronic Hepatitis C patients. Yasmin Saeed, BScPhm, Mohammed Alhokail, Joanna M. Bielecki, BSC, MISt, Lusine Abrahamyan, MD, MPH, PhD, Petros Pechlivanoglou, MSc, PhD, Murray Krahn, MD, MSc, FRCPC, William W. L. Wong, Ph.D.
Health utilities in chronic Hepatitis C patients with late-stage liver disease. Yasmin Saeed, BScPhm, Alice Fried, Mohammed Alhokail, Suzanne Chung, BEd, CCRP, Welson Ryan, Josephine F Wong, MD, Jordan J. Feld, MD, David Wong, MD, FRCP, Hemant Shah, MD, MScCH, Julie Bruneau, MD, Zeny Feng, PhD, Nicholas Mitsakakis, MSc PhD, Jeff Powis, MD, Valeria E. Rac, MD, PhD, Karen E Bremner, BSc, Murray Krahn, MD, MSc, FRCPC and William W. L. Wong, Ph.D
Challenges on the Path to Reimbursement of Oncology Drugs: Insights from the Cost-Effectiveness Decisions of the Pan-Canadian Oncology Drug Review. Alice Fried, Petros Pechlivanoglou, Mohammed Alhokail, Fiona Miller, Murray Krahn
Corneal cross-linking versus penetrating keratoplasty in the treatment of keratoconus: a cost-effectiveness analysis. Victoria Leung, MD, Petros Pechlivanoglou, MSc, PhD, Hall Chew, MD FRCSC, Murray D. Krahn, MD, MSc, Wendy Hatch, OD, MSc
Preferences of pregnant women and family members for combined maternal-fetal health states arising from the use of anticoagulation in pregnancy. Rohan D'Souza, George Tomlinson, PhD, Kyra McKelvey, Danielle Wuebbolt, Vanessa Nguyen, Wynn Peterson, Prakesh Shah, MD, MSc, Karen E Bremner, BSc, Murray Krahn, MD, MSc, FRCPC, Kellie Murphy and Beate Sander, PhD
Characterizing model uncertainty in meta-analysis using a Bayesian method. Chun-Po Fan, PhD, Jeffrey Hoch, PhD, George Tomlinson, PhD,
Posted on Jan 8, 2016